scispace - formally typeset
P

Patricia Rawsthorne

Researcher at University of Manitoba

Publications -  48
Citations -  5473

Patricia Rawsthorne is an academic researcher from University of Manitoba. The author has contributed to research in topics: Population & Inflammatory bowel disease. The author has an hindex of 31, co-authored 48 publications receiving 5076 citations.

Papers
More filters
Journal ArticleDOI

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study

TL;DR: The associations of immune mediated diseases in extraintestinal sites may help to further the understanding of IBD pathogenesis, and it may help in developing a paradigm of disease subsets.
Journal ArticleDOI

Epidemiology of Crohn's Disease and Ulcerative Colitis in a Central Canadian Province: A Population-based Study

TL;DR: The authors have successfully established and validated a population-based database of inflammatory bowel disease based on administrative data and indicate the presence of important environmental risk factors, which warrants further investigation.
Journal ArticleDOI

The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders.

TL;DR: Comparing IBD respondents with and without lifetime anxiety or mood disorder, those with a disorder reported lower quality of life and earlier onset of IBD symptoms and there was a trend toward earlier IBD diagnosis.
Journal ArticleDOI

A Population-Based Case Control Study of Potential Risk Factors for IBD

TL;DR: This study reinforced the increased risk associated with family history, being Jewish, and smoking history, however, a number of significant associations with CD and UC on univariate and multivariate analysis may support the “hygiene hypothesis” and warrant further exploration in prospective studies.
Journal ArticleDOI

The Relationship of Inflammatory Bowel Disease Type and Activity to Psychological Functioning and Quality of Life

TL;DR: Multivariate regression showed that those with active IBD had higher levels of distress, health anxiety, and perceived stress, lower social support, well-being and mastery, and poorer disease-specific QOL, relative to those with inactive disease.